REGULATION OF CYP2B6 IN PRIMARY HUMAN HEPATOCYTES BY PROTOTYPICAL INDUCERS-Reference-Cited by-同舟云学术

REGULATION OF CYP2B6 IN PRIMARY HUMAN HEPATOCYTES BY PROTOTYPICAL INDUCERS

Published:2004-02-20 Issue:3 Volume:32 Page:348-358
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Faucette Stephanie R.,Wang Hongbing,Hamilton Geraldine A.,Jolley Summer L.,Gilbert Darryl,Lindley Celeste,Yan Bingfang,Negishi Masahiko,LeCluyse Edward L.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference49 articles.

1. A Single Nucleotide Polymorphism of CYP2B6 Found in Japanese Enhances Catalytic Activity by Autoactivation

2. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

3. SXR, a novel steroid and xenobioticsensing nuclear receptor

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes;Pharmaceutics;2024-05-30

2. A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment;Biomolecules;2024-01-12

3. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

4. General Framework to Quantitatively Predict Pharmacokinetic Induction Drug–Drug Interactions Using In Vitro Data;Clinical Pharmacokinetics;2023-03-29

5. Genetic Expression of CYP2B6 Gene in Phenobarbitone Responder and Non-responder Neonates;Indian Pediatrics;2023-03